3720 Spectrum Blvd., Suite 125, Tampa, FL 33612

WELCOME TO

SGN Nanopharma

Creating Impactful, Clinically Differentiated Medicines
0 +

Billion

small-molecule pharmaceutical sales annually

0 +

Billion

(small & large molecule) annual pharmaceutical sales in the US alone

0 %

of these small-molecule drugs are constrained by poor delivery of APIs, onerous treatment regimens, slow action times/unwanted side effects

SGN IS DELIVERING THE SOLUTION.

“We firmly believe in the superior power of combination therapeutics to effectively treat complex, chronic diseases with multi-factorial etiologies. When combined with cutting-edge nanotechnologies, the potency, safety, and bioavailability of combination therapeutics are further enhanced. Our commitment is to safely deliver novel, more potent yet safer, combination nano-therapies as an alternative to many traditional medicines such as opiates, which are currently considered over-prescribed and potentially life-threatening.”

Navdeep Jaikaria, Ph.D., Founder, Chairman & CEO

Discover who we are.

Explore our vision, strategy, and capabilities.

Technology

Learn about the technology we employ and intended applications.

Pipeline

Learn about what we're developing and the current stages of our pipeline.

Partnerships

Learn about our strategic partnerships.

Team

Meet our world-class team, board members, and advisory board.

Want to know more?

Let's have a conversation.

Exploring new technologies in pharmaceuticals and their applications to address unmet medical needs remains of paramount interest to us. 


We are committed to making the promise of nanomedicines a reality by delivering clinically superior and cost-effective nanotherapeutics that beat the current gold standards in medicine and significantly improve the quality of global healthcare.

123-removebg-preview